activated Factor XII inhibitors (Bridge Medicines/The Rockefeller University)

N/A

Report date: 2025/03/14 16:20:16
NME

Base Information

Drug Nameactivated Factor XII inhibitors (Bridge Medicines/The Rockefeller University)
Drug Alias NameFactor XIIa inhibitors (Bridge Medicines/The Rockefeller University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor XIIa antagonists
TargetsCoagulation factor XII
Therapy Area/IndicationsInflammationAngioedemas, HereditaryArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Rockefeller University
China Registration ClassN/A

Develop Information

Active CompaniesBridge Medicines Inc
Inactive CompaniesThe Rockefeller University
Active IndicationsInflammationAngioedemas, HereditaryArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A